Tarsus Pharmaceuticals, Inc. revenue for the last year amounted to 182.95 M USD, the most of which — 182.95 M USD — came from its highest performing source at the moment, Therapeutics, the year earlier bringing 17.45 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Tarsus Pharmaceuticals, Inc. 182.95 M USD, and the year before that — 17.45 M USD.